Article thumbnail

Oxygen-dependent and -independent regulation of HIF-1alpha.

By Yang-Sook Chun, Myung-Suk Kim and Jong-Wan Park


Hypoxia-inducible factor-1 (HIF-1) is composed of HIF-1alpha and HIF-1beta, and is a master regulator of oxygen homeostasis, playing critical roles in physiological and pathological processes. Normally, the formation and transcriptional activity of HIF-1 depend on the amount of HIF-1alpha, and the expression of HIF-1alpha is tightly controlled by the cellular oxygen tension. Recent progress in the study of its regulation mechanism provided clues as to how HIF-1alpha is regulated by oxygen. It appears that HIF-1alpha is not regulated only by the oxygen tension, but also by various other stimuli, such as transition metals, nitric oxide, reactive oxygen species, growth factors, and mechanical stresses. In this review, we summarize the oxygen-dependent and -independent regulation of HIF-1alpha, and the respective physiological and pathological meanings

Topics: Research Article
Publisher: Korean Academy of Medical Sciences
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science
  2. (2001). A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha.
  3. (1997). A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA
  4. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol
  5. (2001). Accumulation of HIF-1alpha under the influence of nitric oxide. Blood
  6. (1997). Activa-Regulation of HIF-1 protein 587 tion of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit.
  7. (2000). Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex.
  8. (1996). Activation of hypoxiainducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit.
  9. (2001). Activation of the HIF pathway in cancer. Curr Opin Genet Dev
  10. (2000). Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells.
  11. (2000). Assessment of HER2 status in breast cancer: why, when and how?
  12. (1998). Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer.
  13. (2000). Drosophila von HippelLindau tumor suppressor complex possesses E3 ubiquitin ligase activity.
  14. (2000). Early expression of angiogenesis factors in acute myocardial ischemia and infarction.
  15. (2002). Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res
  16. (1995). Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1.588
  17. (2001). elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell
  18. (1997). Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev
  19. (1991). Enhancer element at the 3′ -flanking region controls transcriptional response to hypoxia in the human erythropoietin gene.
  20. (2001). Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha. Biochem Biophys Res Commun
  21. (2000). Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer
  22. (1996). flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.
  23. (1979). Formation of cobalt protoporphyrin in the liver of rats. A mechanism for the inhibition of liver haem biosynthesis by inorganic cobalt.
  24. (1991). Functional analysis of an oxygen-regulated transcriptional enhancer lying 3′ to the mouse erythropoietin gene.
  25. (1997). Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine.
  26. (2001). HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol
  27. (2000). HIF-1 and human disease: one highly involved factor. Genes Dev
  28. (2001). HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia.
  29. (2001). HIFalpha targeted for VHLmediated destruction by proline hydroxylation: implications for O2 sensing. Science
  30. (1998). Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol
  31. (2000). Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood
  32. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
  33. (1997). Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redoxinduced changes.
  34. (2002). Hypoxia-inducible factor-1alpha/ vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension
  35. (1991). Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene.
  36. (1998). Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res
  37. (2001). Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.
  38. (1998). Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1 alpha. Blood
  39. (1999). Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain.
  40. (1999). Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling.
  41. (1998). Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia.
  42. (2001). Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol
  43. (1998). Insulin induces transcription of target genes through the hypoxiainducible factor HIF-1alpha/ARNT.
  44. (1997). Ischemic preconditioning reduces O2- generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat. Life Sci
  45. (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.
  46. (2000). Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res
  47. (1997). Molecular aspects of oxygen sensing in physiological adaptation to hypoxia. Respir Physiol
  48. (1998). Molecular characterization and chromosomal localization of a third alphaclass hypoxia inducible factor subunit, HIF3alpha. Gene Expr
  49. (1999). Nickelinduced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis
  50. (2002). Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway.
  51. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res
  52. (1986). Oxygen equilibrium study and light absorption spectra of Ni(II)-Fe(II) hybrid hemoglobins.
  53. (1996). Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev
  54. (2001). Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ
  55. (1986). Properties of chemically modified Ni(II)-Fe(II) hybrid hemoglobins. Ni(II) protoporphyrin IX as a model for a permanent deoxy-heme.
  56. (1995). Purification and characterization of hypoxiainducible factor 1.
  57. (2000). Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing.
  58. (1999). Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res
  59. (2002). Recombinant human interleukin (IL)-1beta-mediated regulation of hypoxia-inducible factor-1alpha (HIF-1alpha) stabilization, nuclear translocation and activation requires an antioxidant/ reactive oxygen species (ROS)-sensitive mechanism. Eur Cytokine Netw
  60. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.
  61. (1988). Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science
  62. (2001). Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide.
  63. (2001). Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.
  64. (1998). Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha.
  65. (1997). Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int
  66. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science
  67. (2001). The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology.
  68. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature
  69. (2002). The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorg Med Chem Lett
  70. (1997). Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.
  71. (2000). Zinc induces the accumulation of hypoxia-inducible factor (HIF)-1alpha, but inhibits the nuclear translocation of HIF-1beta, causing HIF-1 inactivation. Biochem Biophys Res Commun